Alzheimer’s disease might start leaving its mark on the brain far earlier than anyone previously realised, according to new research.
For years, the buildup of toxic amyloid plaques has been considered the earliest detectable milestone, picked up on specialised PET scans long before noticeable memory loss sets in. Now, scientists tracking healthy older adults over two decades have discovered distinct structural changes occurring at least seven years before those telltale plaques even show up on a scan.
It suggests the underlying disease process gets going much earlier than standard tests can spot, potentially upending our understanding of how the illness takes root. Uncovering these subtle changes opens up a much wider window for earlier intervention, offering clinicians a chance to step in long before visible brain changes and clinical symptoms take hold.
What doctors currently look for
Right now, the standard way of identifying early Alzheimer’s involves a particular type of brain scan that searches for sticky clumps of protein called amyloid plaques building up inside the brain. These plaques have long been treated as one of the earliest visible markers of the disease, the first real clue that something is going wrong long before someone starts noticing memory problems or confusion in daily life. Doctors and researchers have relied heavily on spotting these plaques as the starting point for identifying who might go on to develop Alzheimer’s, and a huge amount of research into prevention and treatment has been built around targeting them directly.
However, this new research suggests that by the time plaques become visible on a scan, changes may have already been quietly unfolding inside the brain for years beforehand, changes that current scanning technology simply hasn’t been sensitive enough to detect until now.
What the researchers discovered about how Alzheimer’s changes the brain
The study found that physical changes in the structure of the brain, specifically in the thickness of the outer layer known as the cortex, were showing up at least seven years before plaques became detectable using current scanning methods. According to the researcher who led the work, this represents the earliest signal ever picked up on a brain scan in relation to Alzheimer’s disease. That’s important because the earlier a disease process can be tracked, the more opportunity there potentially is to intervene, monitor progression, or eventually develop treatments that work before serious damage has already been done.
The researcher explained that these findings raise an important possibility: that disease processes inside the brain may begin far earlier than even today’s most advanced imaging methods are currently able to pick up. In other words, the seven-year gap identified in this study might not even represent the true starting point of the disease, just the earliest point current technology allows scientists to observe.
How scientists managed to look back in time
To uncover this, researchers followed a group of healthy older adults, tracking their brains using repeated scans over a period stretching nearly two decades. That kind of long-term, detailed data is rare in this field, and it’s exactly what allowed the team to pinpoint the specific point when plaques first became visible in each individual participant, as well as identifying which people went on to develop plaques at all during the study period.
From there, researchers went back through the earlier scans, specifically looking at the decade before plaques would have first appeared, and compared brain structure during that period between two groups: people who eventually developed plaques, and people who never did. This side-by-side comparison across such a long stretch of time is what allowed the subtle, earlier changes to stand out.
A surprising discovery in otherwise healthy brains
What makes this particularly striking is that everyone involved in the study was cognitively healthy at the time of testing, showing no outward signs of memory loss, confusion, or any other symptoms typically associated with dementia. These weren’t people already worried about their memory or showing early warning signs in daily life, they were simply going about their normal lives as healthy older adults.
Despite that, researchers were still able to detect meaningful structural changes in their brains years before any plaques would have shown up on a standard scan. One of the study’s senior researchers, a professor who also heads the research centre behind the work, described this as the most groundbreaking part of the entire study, the fact that measurable changes in brain structure were visible so many years ahead of what’s traditionally considered the very first sign of the disease.
The same researcher noted that Alzheimer’s remains an extremely difficult disease to treat effectively, partly because it’s so closely intertwined with the natural ageing process itself, and is very likely driven by a combination of different biological factors working together, rather than any single, isolated cause.
What might be causing these early changes
These findings raise an interesting question about what’s happening inside the brain before plaques even begin to form in the first place. Researchers say there are two main possible explanations worth considering.
The first possibility is that harmful biological processes, ones that either directly drive plaque buildup or occur as a result of it, may already be quietly underway well before scans are sensitive enough to detect the plaques themselves. Under this explanation, the plaques would still be central to the disease process, just appearing later than the damage that eventually leads to them.
The second, and arguably more significant possibility, is that entirely separate biological processes could be causing measurable changes in the brain even before amyloid plaques start accumulating at all. If this turns out to be the case, it would suggest that plaques themselves might not be the true starting point of Alzheimer’s disease, but rather one visible consequence of something else happening earlier on.
Why this is relevant when it comes to future treatments
If that second explanation proves correct, it would carry real weight for how future Alzheimer’s treatments are developed. Much of the existing research and drug development in this space has focused heavily on targeting amyloid plaques directly, based on the long-standing assumption that they represent the earliest and most important stage of the disease to intervene in.
That being said, if separate processes are actually driving brain changes even earlier than plaque formation, it would suggest researchers need to keep broadening their focus, continuing to develop and test treatments that target other biological processes entirely, rather than concentrating resources solely on amyloid plaques. The researchers behind this study were clear, however, that considerably more research is still needed before any firm conclusions can be drawn about exactly what’s driving these very early changes, or whether targeting them directly could help prevent or slow the disease down the line.
For now, the discovery itself marks a meaningful change in how early Alzheimer’s disease might eventually be detected, potentially giving researchers and doctors a wider window of opportunity to understand, monitor, and one day intervene in a disease that continues to affect a growing number of people as populations around the world age.
